#CRISPRTherapeutics
CRISPR Therapeutics rose in premarket trading after J.P. Morgan initiated coverage with an Overweight rating and a $70 price target.

#CRSP #CRSPStock #CRISPRTherapeutics #CRSPNews #CRSPStockNews #CRISPRTherapeuticsStock #CRISPRTherapeuticsNews #CRISPRTherapeuticsStockNews #GeneEditing #Biotech
CRSP
September 19, 2025 at 12:31 PM
February 3, 2025 at 3:00 PM
The FDA Could Approve The First CRISPR Drug Is Just 6 Months
#crisprtherapeutics #crsp #fda #bullishly #rbccapitalmarkets #brianabrahams

➡️ Now on https://biztoc.comhttps://www.investors.com/news/technology/crsp-stock-pops-as-fda-sets-december-date-to-potentially-ok-gene-editing-drug/
June 9, 2023 at 6:10 PM